[Federal Register Volume 63, Number 249 (Tuesday, December 29, 1998)]
[Notices]
[Pages 71652-71653]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-34376]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Vaccine Advisory Committee (NVAC), Subcommittee on
Future Vaccines, Subcommittee on Immunization Coverage, and
Subcommittee on Vaccine Safety; Meetings
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following Federal advisory committee
meetings.
Name: National Vaccine Advisory Committee (NVAC).
[[Page 71653]]
Times and Dates: 9 a.m.-2 p.m., January 11, 1999; 8:30 a.m.-4
p.m., January 12, 1999.
Place: Hubert H. Humphrey Building, Room 800, 200 Independence
Avenue, SW, Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Notice: In the interest of security, the Department has
instituted stringent procedures for entrance to the Hubert H.
Humphrey Building by non-government employees. Thus, persons without
a government identification card should plan to arrive at the
building each day between 8 and 8:30 a.m. or 12:30 and 1 p.m. to be
escorted to the meeting. Entrance to the meeting at other times
during the day cannot be assured.
Purpose: This committee advises and makes recommendations to the
Director of the National Vaccine Program on matters related to the
Program responsibilities.
Matters to be Discussed: Agenda items will include updates on
the National Vaccine Program Office (NVPO) activities. There will be
a report from the Division of Vaccine Injury Compensation. There
will be discussions on the National Vaccine Advisory Committee roles
and missions; the impact of the Childrens' Health Insurance Plan on
immunization coverage; achieving the goal of polio eradication:
challenges and opportunities; stockpiling vaccines; bioterrorism--
strategies for vaccine readiness; status of a DHHS Vaccine Safety
Action Plan; initiatives in global vaccines--new directions;
influenza pandemic preparedness; Hepatitis B vaccine. There will be
a report from the Assistant Secretary for Health and Surgeon
General. There will be reports from the immunization registries
workgroup; the Subcommittee on Immunization Coverage; Subcommittee
on Future Vaccines; and Subcommittee on Vaccine Safety. There will
be a discussion on future agenda items.
Name: Subcommittee on Immunization Coverage.
Time and Date: 2:30 p.m.-5 p.m., January 11, 1999.
Place: Hubert H. Humphrey Building, Room 800, 200 Independence
Avenue, SW, Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Purpose: This subcommittee will identify and propose solutions
that provide a multifaceted and holistic approach to reducing
barriers that result in low immunization coverage for children.
Matters to be Discussed: This subcommittee will give an update
on the status of the Childrens' Health Insurance Plan; there will be
a discussion on adolescent immunization guidelines; the status of
the paper on ``Strategies to Sustain Success in Childhood
Immunizations'' and plan to promote recommendations stated in paper;
an update on guidelines for implementation of new vaccines; an
update on guidelines for adult immunizations.
Name: Subcommittee on Future Vaccines.
Time and Date: 2:30 p.m.-5 p.m., January 11, 1999.
Place: Hubert H. Humphrey Building, Room 405, 200 Independence
Avenue, SW, Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Purpose: The Subcommittee on Future Vaccines will develop policy
options and guide national activities which will lead to accelerated
development, licensure, and best use of new vaccines in the simplest
possible immunization schedules.
Matters to be Discussed: This subcommittee will hold discussions
regarding agenda items for a joint NVAC/NVPO/CVI meeting on ``orphan
vaccines; vaccines for which development is impeded for a variety of
reasons; an update on the issues of indemnification in relation to
vaccine clinical trials.
Name: Subcommittee on Vaccine Safety.
Time and Date: 2:30 p.m.-5 p.m., January 11, 1999.
Place: Hubert H. Humphrey Building, Room 425A, 200 Independence
Avenue, SW, Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Purpose: This subcommittee will review issues relevant to
vaccine safety and adverse reactions to vaccines.
Matters to be Discussed: This subcommittee will discuss
Hepatitis B and the France experience; there will be further
discussion on risk communication. Agenda items are subject to change
as priorities dictate.
This notice is being published less than 15 days in advance of
the meeting, due to administrative delays.
CONTACT PERSON FOR MORE INFORMATION: Felecia D. Pearson, Committee
Management Specialist, NVPO, CDC, 1600 Clifton Road, NE, M/S A11,
Atlanta, Georgia 30333. Telephone 404/639-4450.
The director of the Management Analysis and Services Office has
been delegated the authority to sign Federal Register Notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Dated: December 21, 1998.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 98-34376 Filed 12-28-98; 8:45 am]
BILLING CODE 4163-18-P
